Cell Therapy

Advancing Inline Monitoring for Superior Bioreactor Performance
Biotech & Bioprocessing Advancing Inline Monitoring for Superior Bioreactor Performance

In the rapidly evolving landscape of biopharmaceutical manufacturing, capturing real-time data has become pivotal in optimizing bioreactor performance and producing high-quality products. Inline monitoring technologies are at the forefront of this transformation, offering real-time surveillance and

Biopharma Industry Faces Continued Layoffs Amid Financial Challenges
Research & Development Biopharma Industry Faces Continued Layoffs Amid Financial Challenges

The biopharma industry is grappling with a persistent wave of layoffs as companies navigate financial constraints and strategic realignments. Despite hopes for a reprieve in 2024, the sector saw a 3% increase in layoffs compared to the previous year. This trend underscores the ongoing challenges

Study Confirms CAR T Cell Therapy Does Not Cause Secondary Cancers
Research & Development Study Confirms CAR T Cell Therapy Does Not Cause Secondary Cancers

The latest study from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine's Abramson Cancer Center provides compelling evidence that CAR T cell therapy does not induce secondary cancers. This finding comes from an extensive analysis of data involving over 700

Why is Rentschler Exiting the Cell and Gene Therapy Market?
Research & Development Why is Rentschler Exiting the Cell and Gene Therapy Market?

In a surprising move, Rentschler Biopharma announced its decision to withdraw from the cell and gene therapy (CGT) business at its Stevenage, UK facility, marking a significant shift in the company's strategic focus. This decision comes despite recent investments in building advanced capabilities

Is T-VEC an Effective Neoadjuvant Therapy for Basal Cell Carcinoma?
Research & Development Is T-VEC an Effective Neoadjuvant Therapy for Basal Cell Carcinoma?

Basal cell carcinoma (BCC) is the most common cancer worldwide, with its incidence doubling over the past 20 years. Traditional treatments, primarily surgical excision, come with a recurrence risk and potential complications. This article explores the potential of Talimogene laherparepvec (T-VEC),

AI Tool MUNIS Revolutionizes Epitope Prediction for Vaccine Development
Research & Development AI Tool MUNIS Revolutionizes Epitope Prediction for Vaccine Development

A significant breakthrough in vaccine development has been achieved by a collaboration between the Ragon Institute and the Jameel Clinic at MIT, as they unveil MUNIS, a deep learning tool designed to accurately predict CD8+ T cell epitopes. This innovative tool promises to accelerate vaccine

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later